Project Grant HT94252510811
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$935K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The Department of Defense's Military Medical Research and Development (CFDA 12.420) program has awarded a $1,746,810 Project Grant to The Children's Hospital of Philadelphia to conduct research on "Combination Therapy for High-Risk, MYCN-Amplified Neuroblastoma". The award period runs from July 1, 2025 to June 30, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions to address...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The Department of the Army Medical Command awarded a $2,247,531 project grant to The Children's Hospital of Philadelphia through the Military Medical Research and Development program (CFDA 12.420) to conduct a comprehensive evaluation of immune function in patients receiving multimodal therapy for high-risk neuroblastoma. The four-year project beginning September 1, 2022 will apply basic, applied, and advanced biomedical research approaches to transform pediatric cancer care and investigate...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $326,712.00 to The Children's Hospital of Philadelphia Research Institute to conduct a structured lipid nutrition intervention study on symptom management and quality of life. The research will take place from September 1, 2025 to August 31, 2027. The Military Medical Research and Development program supports advanced biomedical research to transform...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $676,117 to The Children's Hospital of Philadelphia Research Institute to conduct research on expanded GAA-GGA chimeric repeats in Friedreich ataxia. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research to address critical health challenges. The award period runs...
The Department of the Army Medical Command awarded $1.393 million to the Children's Research Institute under the Military Medical Research and Development federal grant program (CFDA 12.420) to support an early-phase study evaluating MEK and MDM2 inhibition in patients with neurofibromatosis type 1 and premalignant and malignant peripheral nerve sheath tumors. The Children's Research Institute will conduct the clinical trial through September 2026 to investigate medical solutions for...
This Project Grant award of $894,125.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to understand and target epigenetic vulnerabilities in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors (NF1-MPNST) at Washington University. The research aims to transform healthcare for military service members, veterans, and the public by investigating innovative medical solutions. The 3-year...
The U.S. Defense Health Agency awarded a $777,659 Project Grant to the Children's Research Institute in Washington, D.C. under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the public, with a focus on innovative research addressing critical health challenges. Specifically, the award will fund the "Use of ProResolution and Restorative Pharmacology...
The federal Project Grant award of $624,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award, with a performance period from September 1, 2025, to August 31, 2027, will fund a comprehensive in vivo phenotyping study of fusion-driven pediatric rhabdomyosarcomas conducted by the...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,366,365.00 to The Children's Hospital of Philadelphia (CHOP) to conduct a research study titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The study aims to advance healthcare for children by improving the understanding of brain development in those with neurofibromatosis type 1, a genetic disorder that...